LEVETIRACETAM 750 MG TABLET
For 30 tablets
Pharmacies pay
$3.28 filed
30 × $0.10924 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$7.86 filed
30 × $0.26202 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.4× estimated
Medicare paid 2.4× what pharmacies pay.
Part D averages every strength and form sold under “Levetiracetam*” / “Levetiracetam” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$8.77 estimated
$3.28 + $0.49 (15%) + $5.00 fee per fill = $8.77
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LEVETIRACETAM 750 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as levetiracetam.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 15 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Major Pharmaceuticals and NorthStar RxLLC.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 29 NDCs (National Drug Codes); the FDA directory lists 25 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $3.28 for 30 tablets (30 × $0.10924 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 15 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Lupin Pharmaceuticals, Inc. | 3 | $0.10924 per EA filed |
| Ascend Laboratories, LLC | 2 | $0.10924 per EA filed |
| BluePoint Laboratories | 2 | $0.10924 per EA filed |
| Camber Pharmaceuticals, Inc. | 2 | $0.10924 per EA filed |
| Cranbury Pharmaceuticals, LLC | 2 | $0.10924 per EA filed |
| Mylan Pharmaceuticals Inc. | 2 | $0.10924 per EA filed |
| NorthStar RxLLC | 2 | $0.10924 per EA filed |
| Rising Pharma Holdings, Inc. | 2 | $0.10924 per EA filed |
| ScieGen Pharmaceuticals, Inc. | 2 | $0.10924 per EA filed |
| American Health Packaging | 1 | $0.10924 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.10924 per EA filed |
| Major Pharmaceuticals | 1 | $0.10924 per EA filed |
| Novadoz Pharmaceuticals LLC | 1 | $0.10924 per EA filed |
| Quallent Pharmaceuticals Health LLC | 1 | $0.10924 per EA filed |
| Solco Healthcare US, LLC | 1 | $0.10924 per EA filed |
| Not listed as a package in the FDA directory | 4 | $0.10924 per EA filed |
All 29 NDCs, with labeler and price
- 00378-5617-05 · Mylan Pharmaceuticals Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 00378-5617-78 · Mylan Pharmaceuticals Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 00904-7125-61 · Major Pharmaceuticals · $0.10924 per EA · eff. 2026-09-23 filed
- 16571-0789-12 · not listed as a package in the FDA directory · $0.10924 per EA · eff. 2026-09-23 filed
- 16571-0789-50 · not listed as a package in the FDA directory · $0.10924 per EA · eff. 2026-09-23 filed
- 16714-0537-01 · NorthStar RxLLC · $0.10924 per EA · eff. 2026-09-23 filed
- 16714-0537-02 · NorthStar RxLLC · $0.10924 per EA · eff. 2026-09-23 filed
- 27808-0265-01 · Cranbury Pharmaceuticals, LLC · $0.10924 per EA · eff. 2026-09-23 filed
- 27808-0265-02 · Cranbury Pharmaceuticals, LLC · $0.10924 per EA · eff. 2026-09-23 filed
- 31722-0538-05 · Camber Pharmaceuticals, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 31722-0538-12 · Camber Pharmaceuticals, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 42385-0956-12 · not listed as a package in the FDA directory · $0.10924 per EA · eff. 2026-09-23 filed
- 43547-0223-15 · Solco Healthcare US, LLC · $0.10924 per EA · eff. 2026-09-23 filed
- 50228-0472-05 · ScieGen Pharmaceuticals, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 50228-0472-12 · ScieGen Pharmaceuticals, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 64980-0606-12 · Rising Pharma Holdings, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 64980-0606-50 · Rising Pharma Holdings, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 65862-0247-08 · Aurobindo Pharma Limited · $0.10924 per EA · eff. 2026-09-23 filed
- 67877-0770-05 · Ascend Laboratories, LLC · $0.10924 per EA · eff. 2026-09-23 filed
- 67877-0770-12 · Ascend Laboratories, LLC · $0.10924 per EA · eff. 2026-09-23 filed
- 68001-0404-03 · BluePoint Laboratories · $0.10924 per EA · eff. 2026-09-23 filed
- 68001-0404-07 · BluePoint Laboratories · $0.10924 per EA · eff. 2026-09-23 filed
- 68084-0882-01 · American Health Packaging · $0.10924 per EA · eff. 2026-09-23 filed
- 68084-0882-11 · not listed as a package in the FDA directory · $0.10924 per EA · eff. 2026-09-23 filed
- 68180-0114-02 · Lupin Pharmaceuticals, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 68180-0114-09 · Lupin Pharmaceuticals, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 68180-0114-16 · Lupin Pharmaceuticals, Inc. · $0.10924 per EA · eff. 2026-09-23 filed
- 72205-0096-92 · Novadoz Pharmaceuticals LLC · $0.10924 per EA · eff. 2026-09-23 filed
- 82009-0123-05 · Quallent Pharmaceuticals Health LLC · $0.10924 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
17 other products in the NADAC file share the FDA nonproprietary name levetiracetam with LEVETIRACETAM 750 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| KEPPRA 1,000 MG TABLET | $19.8712 per EA filed | We don’t know yet |
| KEPPRA 100 MG/ML ORAL SOLN | $1.91893 per ML filed | We don’t know yet |
| KEPPRA 250 MG TABLET | $8.07857 per EA filed | We don’t know yet |
| KEPPRA 500 MG TABLET | $9.91702 per EA filed | We don’t know yet |
| KEPPRA 750 MG TABLET | $13.46136 per EA filed | We don’t know yet |
| KEPPRA XR 500 MG TABLET | $9.0242 per EA filed | $10.37505 per EA filed |
| KEPPRA XR 750 MG TABLET | $13.48131 per EA filed | $10.37505 per EA filed |
| LEVETIRACETAM 1,000 MG TABLET | $0.15968 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM 100 MG/ML SOLN | $0.03015 per ML filed | We don’t know yet |
| LEVETIRACETAM 250 MG TABLET | $0.05618 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM 500 MG TABLET | $0.07362 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM 750 MG TABLET this page | $0.10924 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM ER 500 MG TABLET | $0.17377 per EA filed | $0.52537 per EA filed |
| LEVETIRACETAM ER 750 MG TABLET | $0.22338 per EA filed | $0.52537 per EA filed |
| ROWEEPRA 500 MG TABLET | $0.07362 per EA filed | We don’t know yet |
| SPRITAM 1,000 MG TABLET | $10.199 per EA filed | $10.47293 per EA filed |
| SPRITAM 250 MG TABLET | $10.27223 per EA filed | $10.47293 per EA filed |
| SPRITAM 500 MG TABLET | $10.2412 per EA filed | $10.47293 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $7.86 for 30 tablets, at an average of $0.26202 per EA in 2024 (2024-01-01 to 2024-12-31) for “Levetiracetam*” and “Levetiracetam”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 4,664,870 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
26 of the product’s 29 NDCs have this Medicare figure; the other 3 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for LEVETIRACETAM 750 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Levetiracetam* / Levetiracetam: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes ORAL point at this name (96 of the 119 the name join matched); NDCs of another route or with no known FDA route do not. 5 of the 96 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code). 108 of 119 NADAC NDCs joined to this name are priced per EA (11 per ML): CMS's average mixes those units.